Press Release – New York, NY – May 26, 2020 – Sichenzia Ross Ference LLP announced today that it represented Relmada Therapeutics, Inc. (NASDAQ: “RLMD”), a clinical stage company developing therapies …
Sichenzia Ross Ference LLP Represents ThinkEquity in $5 Million Public Offering of Medigus Ltd
Press Release – New York, NY – May 22, 2020 – Sichenzia Ross Ference LLP today announced that it represented ThinkEquity, a division of Fordham Financial Management, Inc., as sole book-running manager …
Sichenzia Ross Ference LLP Represents Lexaria Bioscience Corp. in $2 Million Private Placement
Press Release – New York, New York – May 7, 2020 - Sichenzia Ross Ference LLP announced today that it represented Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) in a private placement of common …
Sichenzia Ross Ference LLP Represents Aegis Capital in $3.15 Million Public Offering of Avinger, Inc. Common Stock
Press Release – New York, NY – April 30, 2020 – Sichenzia Ross Ference LLP announced today that it represented Aegis Capital Corp. as sole book runner in an underwritten public offering of 12,600,000 …
Sichenzia Ross Ference LLP Represents Beyond Air in $50 Million At-The-Market Offering
Press Release – New York, NY – April 23, 2020 – Sichenzia Ross Ference LLP announced today that it represented Beyond Air, Inc. (NASDAQ: “XAIR”), a clinical-stage medical device and biopharmaceutical …
Sichenzia Ross Ference LLP Represents Aegis Capital as Sole Bookrunner in $2.9 Million Public Offering of Digital Ally, Inc. Common Stock
Press Release – New York, NY – March 4, 2020 – Sichenzia Ross Ference LLP today announced that it represented Aegis Capital Corp. as sole bookrunner in an underwritten public offering of 2,521,740 …
